Aamal Company announces exclusive agreement between Aamal Medical & Leo Cancer Care

Aamal Company, a prominent player in the healthcare sector, has recently announced a strategic agreement with Leo Cancer Care, a global leader in upright radiotherapy solutions. This exclusive partnership will see Aamal Medical, a subsidiary of Aamal Company, become the exclusive distributor of Leo Cancer Care's cutting-edge technologies within the Middle East and North Africa (MENA) region.

With more than half a century of experience in supplying medical equipment to Qatar’s healthcare sector, Aamal Medical will leverage its extensive market presence to represent Leo Cancer Care’s innovative upright radiotherapy systems. This new agreement not only expands Aamal Medical’s portfolio of specialized healthcare technologies but also aligns with Aamal’s overarching strategy to bolster its healthcare business through strategic partnerships with international innovators.

Leo Cancer Care’s technology stands out due to its unique approach to radiotherapy, which involves positioning patients upright while maintaining a fixed treatment beam. Their Marie solution for particle therapy has already received the necessary approvals, including FDA 510(k) clearance and CE marking, and has successfully treated its first patient.

Moreover, the company is actively developing Grace, its next-generation upright photon therapy solution, with the intention of broadening this approach to conventional radiotherapy as well.

Speaking about the partnership, Gokhan Ozkan, general manager of Aamal Medical, highlighted Aamal Medical’s long-standing commitment to supporting national institutions in Qatar’s efforts to reduce the burden of cancer. He emphasized that upright treatment options have the potential to enhance access to radiotherapy while simultaneously offering a more patient-centric and humane treatment experience.

"This partnership reflects our commitment to equipping healthcare institutions with advanced solutions," stated Ozkan. "By combining our longstanding market experience and relationships with Leo Cancer Care’s technological expertise, we will strengthen our oncology offering and create new opportunities for sustainable growth."

Miha Ulcar, director of Sales EMEA at Leo Cancer Care, expressed enthusiasm about the collaboration, noting that Aamal Medical’s established reputation and extensive reach within Qatar’s healthcare sector will be invaluable in introducing Leo Cancer Care’s upright radiotherapy solutions to the region.

Through this partnership, Aamal Medical aims to forge relationships with healthcare providers interested in adopting upright radiotherapy and expand its presence in specialized cancer treatment technologies. The agreement also provides a platform for Aamal Medical to pursue regional opportunities, further solidifying its ongoing growth in healthcare operations.